For research use only. Not for therapeutic Use.
Oseltamivir Phosphate（Cat No.:A000321）is an antiviral drug used in the treatment and prevention of influenza A and B infections. It inhibits the neuraminidase enzyme, preventing the release of new viral particles from infected cells, thereby reducing the spread of the virus. Oseltamivir is most effective when administered within 48 hours of the onset of symptoms. It is commonly prescribed for patients with influenza or for prophylactic use in individuals exposed to the virus. Oseltamivir is available in oral form, typically as capsules or suspension.
| Catalog Number | A000321 |
| CAS Number | 204255-11-8 |
| Synonyms | NA |
| Molecular Formula | C16H28N2O4 • H3PO4 |
| Purity | ≥95% |
| Target | Influenza Virus |
| Solubility | Limited solubility |
| Storage | 3 years -20C powder |
| Overview of Clinical Research | <span style=”color:#000000;”><span style=”font-size:12px;”><span style=”font-family:arial,helvetica,sans-serif;”>Oseltamivir is a Neuraminidase inhibitor. It is marketed in Influenza virus infections.</span></span></span> |
| IUPAC Name | ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid |
| InChI | InChI=1S/C16H28N2O4.H3O4P/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19;1-5(2,3)4/h9,12-15H,5-8,17H2,1-4H3,(H,18,19);(H3,1,2,3,4)/t13-,14+,15+;/m0./s1 |
| InChIKey | PGZUMBJQJWIWGJ-ONAKXNSWSA-N |
| SMILES | CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O |
| Reference | <span style=”color:#000000;”><span style=”font-size:12px;”><span style=”font-family:arial,helvetica,sans-serif;”>1.Huang, Hua, et al. "Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population." <i style=”font-family: Arial, sans-serif; font-size: 13px;”>The Journal of Maternal-Fetal & Neonatal Medicine</i> 30.11 (2017): 1288-1292.<br /> |
